Majumdar S, Sharma N, Sengar M, Thorat J, et al. A phase II study to evaluate the efficacy of low-dose rasburicase (1.5mg) in adolescent and adult acute leukemia and high-grade lymphomas with tumor lysis syndrome. Leuk Lymphoma 2023 Mar 8:1-11. doi: 10.1080/10428194.2023.2167491.
PMID: 36891578